Ede-Golightly James
SEC insider (Form 3/4/5 filer). CIK 0002048873. Director at Silence Therapeutics plc (SLN). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in LONDON, X0.
Companies Ede-Golightly James has filed insider reports for
- Silence Therapeutics plc (SLN): Director
Ede-Golightly James
CIK: 0002048873
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLN
Silence Therapeutics plc
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 2, 2026SLN
Silence Therapeutics plc
AwardDirectShare Option (Right to Buy)
90K shares- - Dec 22, 2025SLN
Silence Therapeutics plc
AwardDirectShare Option (Right to Buy)
90K shares- - Jan 2, 2025SLN
Silence Therapeutics plc
AwardDirectShare Option (Right to Buy)
48K shares-
1-3 of 3 transactions